Rivaroxaban or Aspirin in Patients With CHD & GD Undergoing PCI
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the efficacy and safety of rivaroxaban or aspirin combined
with clopidogrel in patients with coronary heart disease and gastrointestinal diseases
undergoing PCI.